Using AI to Discover Small Molecule Alternatives to Biologics
The Bio Report
00:00
AI-Driven Drug Discovery Innovations
This chapter explores DeepCure's innovative integration of AI and physics to design small molecule therapies for autoimmune diseases. It discusses the complexities of drug development, the promising results of current AI applications, and the unique challenges tackled by the company, particularly with the BRD4-BD2 inhibitor. Additionally, the chapter emphasizes the transformative potential of automated synthesis platforms and generative AI in enhancing the diversity and efficiency of drug discovery.
Transcript
Play full episode
